Recall D-0234-2023
Description: PROSTAGLANDIN (PE1) 45MCG (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 17MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 20MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 22.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 23MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 30MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 40MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 44.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 45MCG/ML (3ML VIAL) INJECTABLE PROSTAGLANDIN E1 50MCG/ML (1ML VIAL) INJECTION PROSTAGLANDIN E1 60MCG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Recall D-0234-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0234-2023 |
| Event ID | 91332 |
| Distribution | Nationwide in the USA |
| Recall Reason | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. |
| Drug Classification | Class II |
| Drug Code Info | 20230201 |
| Recall Initiation Date | 20221222 |
| Report Date | 20230201 |
| Classification Date | 20230126 |
| Address | 2936 W 17th St Erie, PA 16505-3929 United States |
| Recalling Firm | Pharmacy Innovations |
| Initial Notification | Telephone |
| Similar To |